Allenex AB (publ), a life science company, develops, manufactures, markets, and sells diagnostic products that facilitate transplantation of blood stem cells and organs primarily in Europe and the United States. It offers Olerup SSP product range that are used to type human leukocyte antigen (HLA) alleles based on the SSP technology; SBT Resolver, which is used for sequence based HLA typing; QTYPE, a solution for organ transplantation and other disease conditions; GAMMATYPE, a diagnostics tool for establishing non-HLA compatibility in stem cell transplantation; and XM-ONE, which is used prior to kidney transplantation to detect non-HLA antibodies against the donor’s endothelia. The company’s research portfolio comprises AB0 columns to clean the blood of antibodies directed against the blood group antigen; and an AB0 diagnostic test to measure absorption effects. Allenex AB (publ) sells its products to medical centers and laboratories active in the transplantation of blood stem cells and organs. The company was formerly known as LinkMed AB and changed its name to Allenex AB in June 2011. Allenex AB (publ) was founded in 1998 and is headquartered in Stockholm, Sweden. As of April 5, 2016, Allenex AB (publ) operates as a subsidiary of CareDx, Inc.